Vanguard Group Inc Pulse Biosciences, Inc. Transaction History

Vanguard Group Inc

$5.37 Trillion
Q1 2025

A detailed history of Vanguard Group Inc transactions in Pulse Biosciences, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 843,054 shares of PLSE stock, worth $14.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

843,054

Previous 1,146,339 26.46%

Holding current value

$14.9 Million

Previous $21.2 Million 35.97%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 09, 2025	SELL	$15.61 - $24.56 $4.73 Million - $7.45 Million	-303,285 Reduced 26.46%	843,054 $13.6 Million
Q4 2024 Feb 11, 2025	BUY	$14.56 - $21.08 $2.19 Million - $3.17 Million	150,506 Added 15.11%	1,146,339 $21.2 Million
Q3 2024 Nov 13, 2024	BUY	$10.83 - $21.83 $979,530 - $1.97 Million	90,446 Added 9.99%	995,833 $17.5 Million
Q2 2024 Aug 13, 2024	BUY	$6.69 - $14.54 $389,190 - $845,864	58,175 Added 6.87%	905,387 $10.1 Million
Q1 2024 May 10, 2024	BUY	$7.8 - $11.02 $1.48 Million - $2.09 Million	189,227 Added 28.76%	847,212 $7.38 Million
Q4 2023 Feb 14, 2024	BUY	$3.85 - $12.84 $1.22 Million - $4.06 Million	316,519 Added 92.69%	657,985 $8.05 Million
Q3 2023 Nov 14, 2023	BUY	$4.03 - $8.73 $207,085 - $448,599	51,386 Added 17.71%	341,466 $1.38 Million
Q2 2023 Aug 14, 2023	SELL	$3.67 - $8.64 $1.02 Million - $2.41 Million	-278,555 Reduced 48.99%	290,080 $2.09 Million
Q1 2023 May 15, 2023	BUY	$2.48 - $3.88 $9,575 - $14,980	3,861 Added 0.68%	568,635 $1.91 Million
Q4 2022 Feb 10, 2023	BUY	$1.73 - $2.89 $520 - $869	301 Added 0.05%	564,774 $1.56 Million
Q3 2022 Nov 14, 2022	SELL	$1.23 - $2.3 $29,877 - $55,869	-24,291 Reduced 4.13%	564,473 $1.3 Million
Q2 2022 Aug 12, 2022	SELL	$1.48 - $4.28 $107,529 - $310,963	-72,655 Reduced 10.98%	588,764 $901,000
Q1 2022 May 13, 2022	SELL	$4.21 - $14.79 $15,252 - $53,584	-3,623 Reduced 0.54%	661,419 $3.21 Million
Q4 2021 Feb 14, 2022	SELL	$14.78 - $24.4 $662,336 - $1.09 Million	-44,813 Reduced 6.31%	665,042 $9.85 Million
Q3 2021 Nov 12, 2021	BUY	$17.25 - $26.63 $110,520 - $170,618	6,407 Added 0.91%	709,855 $15.3 Million
Q2 2021 Aug 13, 2021	BUY	$16.31 - $23.64 $11.5 Million - $16.6 Million	703,448 New	703,448 $11.5 Million

Others Institutions Holding PLSE

# of Institutions

Shares Held

5.55M

Call Options Held

76.1K

Put Options Held

60.8K

View Full List

About Pulse Biosciences, Inc.

Ticker PLSE
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 37,125,900
Market Cap $656M
Description
Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using it...

More about PLSE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Pulse Biosciences, Inc. Transaction History